Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2022-11-10 Regulatory Filings
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
111年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (杏輝) providing information about loan balances and endorsement guarantees for the current and previous months. It contains tabulated financial data but is very short (624 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure or compliance update rather than a full financial report or announcement of a meeting or vote. There is no indication of an annual or interim report, earnings release, or management discussion. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2022-11-10 Chinese
111年10月營業收入
Interim / Quarterly Report Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 杏輝, with comparisons to the previous year. It includes financial data such as revenue amounts, percentage changes, and notes on accounting standards (IFRS). The document is short (773 characters) and primarily presents financial summary data for a specific month and year (民國111年10月, which corresponds to October 2022). This matches the characteristics of an Interim / Quarterly Report (IR), as it contains substantive financial data for a period shorter than a full fiscal year. It is not an announcement or a brief summary, but actual financial figures are presented. Therefore, the appropriate classification is IR (Interim / Quarterly Report).
2022-11-10 Chinese
公告本公司設置公司治理主管
Board/Management Information Classification · 100% confidence The document is a short announcement (701 characters) about a personnel change specifically regarding the appointment of a new corporate governance officer (公司治理主管). It includes details such as the new appointee's name, position, and effective date. There is no financial data, no report attached or referenced, and no mention of financial results or regulatory filings beyond this personnel update. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management positions.
2022-11-08 Chinese
本公司董事會決議通過111年第3季合併財務報告案
Interim / Quarterly Report Classification · 95% confidence The document is a formal announcement from the company's financial officer regarding the board's approval of the consolidated financial report for the third quarter of the fiscal year 111 (which corresponds to 2022-2023 in the Gregorian calendar). It includes cumulative financial figures such as revenue, gross profit, operating profit, net profit before tax, net profit, net profit attributable to parent company owners, earnings per share, total assets, total liabilities, and equity as of the period ending 111/09/30. The document is relatively short (908 characters) and appears to be a regulatory announcement of the approval of the quarterly financial report rather than the full report itself. It does not contain detailed financial statements or substantive analysis but summarizes key financial data and the board's resolution. Therefore, it fits best as an Interim / Quarterly Report (IR) since it reports comprehensive financial data for a period shorter than a full fiscal year (Q3). The document is not merely an announcement of report publication (RPA) because it includes substantive financial data, nor is it a certification or other regulatory filing (RNS).
2022-11-08 Chinese
111年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data listing shareholdings of company insiders, including directors, chairpersons, general managers, and their family members. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider shareholdings and transactions, not on financial results, management changes, or other report types. There is no indication of a full financial report, earnings release, or meeting materials. The document is not a brief announcement but a detailed disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades).
2022-10-11 Chinese
111年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors, supervisors, and senior management. It lists individual names, titles, share counts, and pledge ratios. The content focuses on insider shareholdings and related disclosures. There is no indication of financial results, earnings, management discussion, or regulatory certifications. The document is not a report or announcement of a meeting or vote. It is a notification of insider shareholdings and pledges, which aligns with the definition of Director's Dealing (DIRS) filings, which report personal share transactions or holdings by company directors and executives. The document length is 3343 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement. Therefore, the best classification is DIRS with high confidence.
2022-10-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.